Hormone Replacement Therapy and Inflammation
Andrew P. Miller(University of Alabama at Birmingham), Suzanne Oparil(University of Alabama at Birmingham), Dongqi Xing(University of Alabama at Birmingham), Wenguang Feng(Inner Mongolia Medical University), Yiu-Fai Chen(University of Alabama at Birmingham)
Cited by 81
Related Papers
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k